An observational study in Cystic Fibrosis (CF) and Cystic Fibrosis in Children, sponsored by Izmir Democracy University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 6 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-03-27.
Sponsored by Izmir Democracy University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 49 studies in Cystic Fibrosis with a site in Turkey — 4 open to participants now, 4 under way, none of them phase 3. Cystic Fibrosis · Turkey.
Among the 49 studies in Cystic Fibrosis with a site in Turkey, this one is the 12th largest by planned enrollment of the 27 observational ones that give a count, is one of 4 that started in 2025, is one of 27 observational ones, and was the 43rd registered.
1,622 studies on the registry are indexed under Cystic Fibrosis; 201 are open to participants now.
Browse Cystic Fibrosis studies →4 of the 49 studies in Cystic Fibrosis with a site in Turkey are open now. Recruiting first, the newest first:
Hacettepe University · Sites in Turkey
Ages 8–18
Hacettepe University · Sites in Turkey
Ages 18–45 · Healthy volunteers
büşra başpınar · Sites in Turkey
Ages 6–18
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 156 Cystic Fibrosis studies recruiting now, 95 (61%) set no upper age limit and 45 (29%) stop at 75 or younger; 87 take children under 18; 42 take healthy volunteers.
This study: 6 Years to 18 Years · all sexes.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
49 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 4 started in 2025.
This study's planned enrollment of 50 is below the median of 86 across 504 observational studies indexed under Cystic Fibrosis.
Median enrollment 35 across the 22 interventional studies, 50 across the 27 observational. Of the 42 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 49 have an industry lead sponsor. The 10 most frequent:
Izmir Democracy University is the lead sponsor of 78 studies on the registry; 32 are open to participants now.
Izmir Democracy University has 1 study filed under Cystic Fibrosis — fewer than ten, so there is no comparison to draw.
2 of the studies in Cystic Fibrosis with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06984679Izmir Democracy UniversityPhysical Impairments in Children With Cystic Fibrosis | 2027-03-01 |
| NCT07930221Hacettepe UniversityThe Effects of Yoga Practice on Exercise Capacity, Arterial Stiffness, Respiratory Function, Peripheral Muscle Strength, Posture and Quality of Life in Children With Cystic Fibrosis | 2027-07 |
Add all 2 to your calendar (.ics) → With an account.
Among the 49 studies in Cystic Fibrosis with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
It is aimed to reveal impairments regarding urinary incontinence, dyspnea, muscle strength, functional capacity or quality of life in children and adolescents with cystic fibrosis compared to healthy children and adolescents.
This study aims to compare dyspnea, functional capacity, muscle strength, urinary incontinence and quality of life between children and adolescents with cystic fibrosis and healthy children and adolescents. Participants will be assessed for these parameters through clinical evaluations, exercise tests, questionnaires and measurements. The study aims to understand the health implications of cystic fibrosis and provide the basis for improvements in the health management of these individuals.
At least 25 patients with cystic fibrosis will be included in the main group and at least 25 healthy individuals will be included in the control group.
Inclusion Criteria for Children and Adolescents with Cystic Fibrosis:
Inclusion Criteria for Healthy Children and Adolescents:
Exclusion Criteria for Children and Adolescents with Cystic Fibrosis:
Exclusion Criteria for Healthy Children and Adolescents:
This group will consist of children and adolescents with cystic fibrosis.
Other: Physical Evaluations in Children with Cystic Fibrosis
This group will consist of healthy children and adolescents.
Other: Physical Evaluations in Healthy Children
In this study, dyspnea, functional capacity, muscle strength, urinary incontinence and quality of life will be evaluated in children and adolescents with cystic fibrosis. The data to be obtained through all these evaluations will be done face to face within 45-60 minutes.
In this study, dyspnea, functional capacity, muscle strength, urinary incontinence and quality of life will be evaluated in healthy children and adolescents. The data to be obtained from all these assessments will be made face to face within 45-60 minutes.
Hand Grip Strength
Grip strength will be measured using a dynamometer. Each hand will be tested three times, and the highest value will be recorded for both sides.
Time frame: through study completion, an average of 1 year
Dyspnea score
Dyspnea will be assessed with the Modified Medical Research Council (MMRC) Dyspnea Scale, scored from 0 (no dyspnea) to 4 (maximum severity).
Time frame: through study completion, an average of 1 year
Pulmonary Function Test Evaluation
Lung function will be assessed with a spirometer. The highest value of the three measurements will be used and interpreted according to gender, age, weight and height. A value below 80% of the expected value will be interpreted as abnormal.
Time frame: through study completion, an average of 1 year
Respiratory Muscle Strength Evaluation
Respiratory muscle strength will be assessed with a spirometer. The test will be conducted with the participant seated, using a mouthpiece and a nose clip. The highest value for inspiratory and expiratory pressure will be recorded. A value below 80% of the expected value will be interpreted as abnormal.
Time frame: through study completion, an average of 1 year
Cough Strength Evaluation
The peak cough expiratory flow of the individual will be assessed using a peak flow meter. The best of at least three repetitions is recorded.A value above 450 indicates effective cough.
Time frame: through study completion, an average of 1 year
Aerobic Exercise Capacity Evaluation
Aerobic capacity will be assessed twice via 6-minute walk test. The longest distance will be used for analysis. A value below 80% of the expected value will be interpreted as abnormal.
Time frame: through study completion, an average of 1 year
Anaerobic Exercise Capacity Evaluation
Anaerobic capacity will be assessed via the 3-minute step test (3-STT). For the 3-STT, participants will rest for 10 minutes before performing the test with a 15 cm step at a rate of 30 steps per minute, controlled by a metronome. The total number of steps will be recorded.A high number of steps indicates good capacity.
Time frame: through study completion, an average of 1 year
Quality of Life Score
The scale we will use to assess health-related quality of life, the Pediatric Quality of Life Inventory (PedsQL 4.0). The scale was developed to assess the health-related quality of life of children and adolescents between the ages of 2 and 18 and consists of physical, emotional, social and school functioning items, totaling 23 items.Scores from this questionnaire are converted to a scale of 0 to 100. Higher scores indicate better health-related quality of life.
Time frame: through study completion, an average of 1 year
Urinary incontinence score
Urinary incontinence will be assessed using the Voiding Dysfunction Symptom Score, a 15-item questionnaire. A score above 8.5 indicates the presence of lower urinary tract symptoms.
Time frame: through study completion, an average of 1 year
Plan to share: No
Started Sep 2025 (actual). Primary completion is estimated for Mar 2027, 17 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Izmir Democracy University